Topoisomerase 2β mutation impairs early B-cell development

Blood. 2020 Apr 23;135(17):1497-1501. doi: 10.1182/blood.2019003299.

Olivier Papapietro ¹ ², Anita Chandra ¹ ³, Davide Eletto ¹, Sarah Inglott ⁴, Vincent Plagnol ⁵, James Curtis ¹, Mailis Maes ¹, Ali Alisaac ¹ ⁶, Adriana S Albuquerque ⁷, Eugenie Basseres ², Olivier Hermine ⁸ ⁹, Capucine Picard ⁹ ¹⁰ ¹¹, Alain Fischer ⁸ ⁹ ¹¹ ¹², Anne Durandy ⁸ ¹³, Sven Kracker ⁸ ¹³, Siobhan O Burns ⁷ ¹⁴, Delphine Cuchet-Lourenco ¹, Klaus Okkenhaug ³, Sergey Nejentsev ¹ ²

Affiliations

1 Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
2 Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
3 Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
4 Great Ormond Street Hospital National Health Service Trust, London, United Kingdom.
5 University College London Genetics Institute, London, United Kingdom.
6 College of Applied Sciences, Al Baha University, Al Baha, Saudi Arabia.
7 University College London Institute of Immunity and Transplantation, London, United Kingdom.
8 Imagine Institute, University Paris Descartes Sorbonne Paris Cité, Paris, France.
9 INSERM UMR 1163, Paris, France.
10 Study Center for Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Paris, France.
11 Department of Pediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
12 Collège de France, Paris, France.
13 Human Lymphohaematopoiesis Laboratory, INSERM UMR 1163, Paris, France; and.
14 Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.

PMID: 32128574 DOI: 10.1182/blood.2019003299

Name
Email *

	Sorry, but the email address you supplied was invalid.